Delayed bleeding monitoring and lab follow-up for anticoagulant hold and UTI
Summary
The facility failed to monitor for signs and symptoms of bleeding and failed to follow up with the provider to reinstate an anticoagulant for a resident who was comatose, dependent on staff for activities of daily living, receiving tube feeding, oxygen, tracheostomy care, oral suctioning, and gastrostomy tube care. The resident had diagnoses including stroke, atrial fibrillation, heart failure, hypertension, nontraumatic intracerebral hemorrhage, acute and chronic respiratory failure, persistent vegetative state, autonomic dysreflexia, and unspecified convulsions. The resident received Eliquis twice daily until the morning dose on 3/9/26, when dark red urine was noted and the on-call NP was contacted. The on-call NP directed staff to continue monitoring and to continue Eliquis due to clotting risk, and later that day the resident’s NP was updated and held the Eliquis. After the anticoagulant was held, documentation showed ongoing blood in the urine, but the record lacked documentation of continued bleeding monitoring after 3/10/26. The EMR also showed that the order was treated as held/discontinued because the computer system discontinued medications placed on hold, and the facility did not clarify the hold order. The resident’s family member reported that blood in the urine was first observed and reported to nursing, that no further bleeding was seen after that point, and that on a later visit the Eliquis had still been on hold until the family member asked staff to contact the NP to restart it. The ADON confirmed the lack of documentation for further bleeding monitoring and stated the facility failed to clarify the hold order. The facility also failed to obtain laboratory results and update the primary provider in a timely manner to initiate treatment for a urinary infection. A urine sample was collected after dark red urine was noted, but the first specimen was cancelled by the laboratory because the resident’s name was misspelled. A second specimen was collected and sent, and the urinalysis was reviewed with the NP, who instructed staff to wait for culture results because the nitrate result was negative. The culture later showed growth of more than 100,000 CFU/ml Escherichia coli and more than 100,000 CFU/ml Proteus mirabilis, but the progress notes lacked documentation of culture follow-up or provider contact for antibiotic orders, and the MAR did not show an antibiotic. Interviews with the family member and facility staff confirmed that the culture results were available before the provider was contacted and that the delay in follow-up occurred despite the facility’s expectation that lab results be reviewed and reported promptly.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.